Cases
Cases 11 - 20 of 98
C. et al v. Blue Cross Blue Shield of Massachusetts Inc We have downloadable decisions or orders for this case
as 1:2018cv12278
Plaintiff: Jane Doe, Kelly W. and Steve C.
Defendant: Blue Cross Blue Shield of Massachusetts Inc
Cause Of Action: 29 U.S.C. § 1132
Blue Cross Blue Shield Association et al v. GlaxoSmithKline LLC et al
as 3:2018mc00010
Plaintiff: Blue Cross Blue Shield Association, Aetna, Inc., Amerigroup/HMS and others
Defendant: GlaxoSmithKline LLC
Respondent: Mark D. Fischer and Rawlings & Associates, PLLC
UNIVERSITY SPINE CENTER v. BLUE CROSS BLUE SHIELD OF MASSACHUSETTS et al
as 2:2018cv02873
Plaintiff: UNIVERSITY SPINE CENTER
Defendant: BLUE CROSS BLUE SHIELD OF MASSACHUSETTS and JOHN DOE
Cause Of Action: 29 U.S.C. § 1132
MED-X GLOBAL, LLC v. WORLDWIDE INSURANCE SERVICES, LLC (T/N GEOBLUE) et al We have downloadable decisions or orders for this case
as 3:2017cv11742
Plaintiff: MED-X GLOBAL, LLC
Defendant: WORLDWIDE INSURANCE SERVICES, LLC (T/N GEOBLUE) , HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY , BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. (T/N FLORIDA BLUE) and others
Cause Of Action: 29 U.S.C. § 1132
LI Neuroscience Specialists v. Blue Cross Blue Shield of Massachusetts We have downloadable decisions or orders for this case
as 1:2017cv06572
Defendant: Blue Cross Blue Shield of Massachusetts
Plaintiff: LI Neuroscience Specialists
Cause Of Action: 29 U.S.C. § 1132 E.R.I.S.A.-Employee Benefits
In re: Lorazepam & Clorazepate Antitr, et al v. Mylan Laboratories, Inc., et al
as 17-7136
In Re: In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee: Blue Cross & Blue Shield of Minnesota, a Minnesota Corpoation, Blue Cross & Blue Shield of Massachusetts, a Massachusetts Corporation, Federated Mutual Insurance Company, a Minnesota Corporation and others
Defendant - Appellee: Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellant: Cambrex Corporation and Gyma Laboratories of America, Inc.
In re: Lorazepam & Clorazepate Antitr, et al v. Mylan Laboratories, Inc., et al
as 17-7135
In Re: In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee: Blue Cross & Blue Shield of Minnesota, a Minnesota Corpoation, Blue Cross & Blue Shield of Massachusetts, a Massachusetts Corporation, Federated Mutual Insurance Company, a Minnesota Corporation and others
Defendant - Appellant: Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellee: Cambrex Corporation and Gyma Laboratories of America, Inc.
Blue Cross and Blue Shield of Massachusetts, Inc., et al. v. Takeda Pharmaceuticals America Inc. et al
as 1:2017cv11663
Plaintiff: Blue Cross & Blue Shield of Massachusetts, Inc.
Defendant: Takeda Pharmaceuticals America Inc , Takeda Pharmaceuticals U S A Inc , Takeda California Inc and others
Cause Of Action: 28 U.S.C. § 1332
Blue Cross and Blue Shield of Massachusetts, Inc. v. Takeda Pharmaceuticals America, Inc. et al
as 1:2017cv11665
Defendant: Takeda Pharmaceuticals America Inc , Takeda Pharmaceuticals U S A Inc , Takeda California Inc and others
Plaintiff: Blue Cross & Blue Shield of Massachusetts, Inc.
Cause Of Action: 28 U.S.C. § 1332
Blue Cross and Blue Shield of Massachusetts, Inc., et al. v. Takeda Pharmaceuticals America Inc. et al
as 1:2017cv11661
Plaintiff: Blue Cross & Blue Shield of Massachusetts, Inc.
Defendant: Takeda Pharmaceuticals America Inc , Takeda Pharmaceuticals U S A Inc , Takeda California Inc and others
Cause Of Action: 28 U.S.C. § 1332

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?